UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
NYSE:UTI • US9139151040
31.03 USD
+0.68 (+2.24%)
Last: Feb 17, 2026, 02:50 PM
Taking everything into account, UTI scores 5 out of 10 in our fundamental rating. UTI was compared to 75 industry peers in the Diversified Consumer Services industry. UTI scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, UTI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year UTI was profitable.
- UTI had a positive operating cash flow in the past year.
- In the past 5 years UTI has always been profitable.
- In the past 5 years UTI always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 6.44%, UTI is doing good in the industry, outperforming 72.00% of the companies in the same industry.
- The Return On Equity of UTI (15.98%) is better than 74.67% of its industry peers.
- UTI's Return On Invested Capital of 8.69% is fine compared to the rest of the industry. UTI outperforms 76.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for UTI is below the industry average of 10.88%.
- The 3 year average ROIC (7.27%) for UTI is below the current ROIC(8.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.44% | ||
| ROE | 15.98% | ||
| ROIC | 8.69% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
1.3 Margins
- UTI has a better Profit Margin (6.28%) than 65.33% of its industry peers.
- In the last couple of years the Profit Margin of UTI has grown nicely.
- Looking at the Operating Margin, with a value of 8.38%, UTI is in the better half of the industry, outperforming 65.33% of the companies in the same industry.
- In the last couple of years the Operating Margin of UTI has grown nicely.
- The Gross Margin of UTI (49.62%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of UTI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.38% | ||
| PM (TTM) | 6.28% | ||
| GM | 49.62% |
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UTI is creating some value.
- UTI has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for UTI has been increased compared to 5 years ago.
- Compared to 1 year ago, UTI has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.56 indicates that UTI is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.56, UTI belongs to the top of the industry, outperforming 81.33% of the companies in the same industry.
- UTI has a debt to FCF ratio of 6.28. This is a slightly negative value and a sign of low solvency as UTI would need 6.28 years to pay back of all of its debts.
- UTI's Debt to FCF ratio of 6.28 is fine compared to the rest of the industry. UTI outperforms 73.33% of its industry peers.
- UTI has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.29, UTI perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 6.28 | ||
| Altman-Z | 3.56 |
ROIC/WACC1.03
WACC8.44%
2.3 Liquidity
- UTI has a Current Ratio of 1.14. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of UTI (1.14) is comparable to the rest of the industry.
- A Quick Ratio of 1.14 indicates that UTI should not have too much problems paying its short term obligations.
- UTI has a Quick ratio of 1.14. This is comparable to the rest of the industry: UTI outperforms 50.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
- The earnings per share for UTI have decreased by 0.00% in the last year.
- UTI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 65.96% yearly.
- The Revenue has grown by 12.59% in the past year. This is quite good.
- Measured over the past years, UTI shows a very strong growth in Revenue. The Revenue has been growing by 22.67% on average per year.
EPS 1Y (TTM)0%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%-42.5%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%9.64%
3.2 Future
- The Earnings Per Share is expected to grow by 6.67% on average over the next years.
- The Revenue is expected to grow by 9.17% on average over the next years. This is quite good.
EPS Next Y-31.68%
EPS Next 2Y-11.51%
EPS Next 3Y6.67%
EPS Next 5YN/A
Revenue Next Year9.25%
Revenue Next 2Y8.99%
Revenue Next 3Y9.17%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 31.99, the valuation of UTI can be described as expensive.
- UTI's Price/Earnings ratio is in line with the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.19, UTI is valued at the same level.
- With a Price/Forward Earnings ratio of 34.76, UTI can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of UTI is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of UTI to the average of the S&P500 Index (28.06), we can say UTI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.99 | ||
| Fwd PE | 34.76 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as UTI.
- UTI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UTI is cheaper than 61.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 105.79 | ||
| EV/EBITDA | 14.58 |
4.3 Compensation for Growth
- UTI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.48
EPS Next 2Y-11.51%
EPS Next 3Y6.67%
5. Dividend
5.1 Amount
- No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:UTI (2/17/2026, 2:50:27 PM)
31.03
+0.68 (+2.24%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-04 2026-02-04/amc
Earnings (Next)05-05 2026-05-05
Inst Owners97.52%
Inst Owner Change-0.19%
Ins Owners2.78%
Ins Owner Change4.87%
Market Cap1.71B
Revenue(TTM)855.03M
Net Income(TTM)53.69M
Analysts81.82
Price Target38.18 (23.04%)
Short Float %4.56%
Short Ratio3.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.57%
Min EPS beat(2)28.91%
Max EPS beat(2)66.22%
EPS beat(4)4
Avg EPS beat(4)59.42%
Min EPS beat(4)28.91%
Max EPS beat(4)73.27%
EPS beat(8)7
Avg EPS beat(8)48.68%
EPS beat(12)11
Avg EPS beat(12)85.96%
EPS beat(16)14
Avg EPS beat(16)183.11%
Revenue beat(2)2
Avg Revenue beat(2)0.64%
Min Revenue beat(2)0.47%
Max Revenue beat(2)0.82%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.47%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.01%
Revenue beat(12)12
Avg Revenue beat(12)2.35%
Revenue beat(16)15
Avg Revenue beat(16)2.9%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-46.05%
EPS NQ rev (3m)-80.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.43%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.99 | ||
| Fwd PE | 34.76 | ||
| P/S | 2 | ||
| P/FCF | 105.79 | ||
| P/OCF | 22.04 | ||
| P/B | 5.08 | ||
| P/tB | 5.96 | ||
| EV/EBITDA | 14.58 |
EPS(TTM)0.97
EY3.13%
EPS(NY)0.89
Fwd EY2.88%
FCF(TTM)0.29
FCFY0.95%
OCF(TTM)1.41
OCFY4.54%
SpS15.54
BVpS6.11
TBVpS5.21
PEG (NY)N/A
PEG (5Y)0.48
Graham Number11.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.44% | ||
| ROE | 15.98% | ||
| ROCE | 11.63% | ||
| ROIC | 8.69% | ||
| ROICexc | 11.82% | ||
| ROICexgc | 13.27% | ||
| OM | 8.38% | ||
| PM (TTM) | 6.28% | ||
| GM | 49.62% | ||
| FCFM | 1.89% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
ROICexc(3y)10.21%
ROICexc(5y)8.25%
ROICexgc(3y)11.54%
ROICexgc(5y)9.21%
ROCE(3y)9.72%
ROCE(5y)7.88%
ROICexgc growth 3Y34.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y33.76%
ROICexc growth 5YN/A
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
F-Score7
Asset Turnover1.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 6.28 | ||
| Debt/EBITDA | 0.93 | ||
| Cap/Depr | 181.06% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 73.39% | ||
| Profit Quality | 30.06% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 3.56 |
F-Score7
WACC8.44%
ROIC/WACC1.03
Cap/Depr(3y)145.01%
Cap/Depr(5y)268.95%
Cap/Sales(3y)5.89%
Cap/Sales(5y)11.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%-42.5%
EPS Next Y-31.68%
EPS Next 2Y-11.51%
EPS Next 3Y6.67%
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%9.64%
Revenue Next Year9.25%
Revenue Next 2Y8.99%
Revenue Next 3Y9.17%
Revenue Next 5YN/A
EBIT growth 1Y-0.64%
EBIT growth 3Y47.33%
EBIT growth 5YN/A
EBIT Next Year46.16%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.76%
FCF growth 3YN/A
FCF growth 5Y99.08%
OCF growth 1Y35.47%
OCF growth 3Y28.35%
OCF growth 5Y54.57%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
What is the valuation status for UTI stock?
ChartMill assigns a valuation rating of 3 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
Can you provide the financial health for UTI stock?
The financial health rating of UNIVERSAL TECHNICAL INSTITUT (UTI) is 5 / 10.
What is the earnings growth outlook for UNIVERSAL TECHNICAL INSTITUT?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -31.68% in the next year.